Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
With every discovery through clinical studies, we can offer more people the chance for a healthier future.
The most common side effects are gastrointestinal, such as nausea, vomiting, and diarrhea
For many patients, especially those whose primary challenge is appetite control, this mechanism is sufficient to support meaningful and sustainable weight loss
Same once-daily injection, same compounding pharmacy, broader anti-inflammatory coverage where the surgical field calls for it
On the one hand, GLP-1 RAs enhance insulin release and inhibit glucagon secretion, leading to a reduction in hepatic glucose production
The exception: in March 2024, the FDA approved a supplemental indication for semaglutide 2.4 mg (Wegovy) to reduce the risk of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke in adults with established cardiovascular disease and either obesity or overweight (SELECT trial, Lincoff et al., New England Journal of Medicine 2023)
